Literature DB >> 6319753

Tumor induction by simian virus 40 in mice is controlled by long-term persistence of the viral genome and the immune response of the host.

J Abramczuk, S Pan, G Maul, B B Knowles.   

Abstract

Simian virus 40 (SV40), which transforms mouse cells in vitro, has not been previously observed to cause tumors when injected in immunocompetent mice. We have investigated both the fate of the injected virion in mice and several immunological parameters as potential factors controlling tumorigenicity. We find that although SV40 does not replicate in mouse cells, the viral DNA can persist for many months postinjection; the majority of the viral DNA is found in the cytoplasm, but a small amount of the viral DNA is integrated at multiple sites in the host nuclear DNA. The persistence of the viral genome is independent of the ability of the mouse to mount an SV40 TSTA specific cytotoxic T-cell response and may be attributed to the cytoplasmic location of the majority of the viral genome. However, in long-term studies of SV40-injected mice, genetically identical except for the major histocompatibility complex, we find that tumors were induced in some mice of the H-2d (low cytotoxic T-lymphocyte responder to SV40 TSTA) but not of the H-2k (high responder to SV40 TSTA) haplotype. Thus, a combination of inefficient disposal of the injected virion and inefficient immunological surveillance and elimination of cells containing nuclear SV40 DNA can eventually result in SV40-induced tumors at multiple sites in mice.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319753      PMCID: PMC255495     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  ASPECTS OF THE PATHOGENESIS OF VIRUS DISEASES.

Authors:  C A MIMS
Journal:  Bacteriol Rev       Date:  1964-03

2.  Quantitation of Simian virus 40 sequences in African green monkey, mouse and virus-transformed cell genomes.

Authors:  L D Gelb; D E Kohne; M A Martin
Journal:  J Mol Biol       Date:  1971-04-14       Impact factor: 5.469

3.  SV40-tumorigenesis in mouse.

Authors:  T Wesslén
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

4.  Rapid concentration and purification of polyoma virus and SV40 with polyethylene glycol.

Authors:  T Friedmann; M Haas
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

5.  Transplantable mouse tumor line induced by injection of SV40-transformed mouse kidney cells.

Authors:  S Kit; T Kurimura; D R Dubbs
Journal:  Int J Cancer       Date:  1969-07-15       Impact factor: 7.396

6.  Genetic analysis of simian virus 40. I. Description of microtitration and replica-plating techniques for virus.

Authors:  J A Robb; R G Martin
Journal:  Virology       Date:  1970-08       Impact factor: 3.616

7.  Establishment of a cell line from an inbred mouse strain for viral transformation studies: simian virus 40 transformation and tumor production.

Authors:  K K Takemoto; R C Ting; H L Ozer; P Fabisch
Journal:  J Natl Cancer Inst       Date:  1968-12       Impact factor: 13.506

8.  Basis for the acquisition of malignant potential by mouse cells cultivated in vitro.

Authors:  S A Aaronson; G J Todaro
Journal:  Science       Date:  1968-11-29       Impact factor: 47.728

9.  An electron microscopical study of the uptake of foreign particles by the livers of foetal and adult rats.

Authors:  J R Casley-Smith; P C Reade
Journal:  Br J Exp Pathol       Date:  1965-10

10.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

View more
  9 in total

1.  Dissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants.

Authors:  S S Tevethia; M Lewis; Y Tanaka; J Milici; B Knowles; W L Maloy; R Anderson
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

2.  Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas.

Authors:  I Marton; S E Johnson; I Damjanov; K S Currier; J P Sundberg; B B Knowles
Journal:  Transgenic Res       Date:  2000-04       Impact factor: 2.788

3.  Analysis of a transgenic mouse containing simian virus 40 and v-myc sequences.

Authors:  J A Small; D G Blair; S D Showalter; G A Scangos
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

4.  Immunologic selection of simian virus 40 (SV40) T-antigen-negative tumor cells which arise by excision of early SV40 DNA.

Authors:  P T Mora; C L Parrott; K Baksi; V McFarland
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

5.  Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes.

Authors:  L M Mylin; T D Schell; D Roberts; M Epler; A Boesteanu; E J Collins; J A Frelinger; S Joyce; S S Tevethia
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors.

Authors:  R L Brinster; H Y Chen; A Messing; T van Dyke; A J Levine; R D Palmiter
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

7.  Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.

Authors:  X Ye; J McCarrick; L Jewett; B B Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Early regions of JC virus and BK virus induce distinct and tissue-specific tumors in transgenic mice.

Authors:  J A Small; G Khoury; G Jay; P M Howley; G A Scangos
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

9.  Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.

Authors:  S J Faas; S Pan; C A Pinkert; R L Brinster; B B Knowles
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.